Description
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Zidovudine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Abacavir, Zidovudine and Lamivudine Tablets
  • Zidovudine and Lamivudine Tablets
  • Zidovudine Capsules
  • Zidovudine Infusion
  • Abacavir Tablets
  • Zidovudine Tablets

  • Biochem/physiol Actions
    Reverse transcriptase inhibitor active against HIV-1 virus.
    Packaging
    Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
    Other Notes
    Sales restrictions may apply.
    Specifications

    General

    NACRESNA.24
    UNSPSC Code41116107
    Beilstein/REAXYS Number3595791
    MDL numberMFCD00006536
    SMILES stringCC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
    InChI1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1
    InChI keyHBOMLICNUCNMMY-XLPZGREQSA-N
    gradepharmaceutical primary standard
    API familyzidovudine
    formsolid
    shelf lifelimited shelf life, expiry date on the label
    manufacturer/tradenameBP
    mp113-115 °C (lit.)
    application(s)pharmaceuticalpharmaceutical small molecule
    formatneat
    storage temp.2-8°C
    Merck BP803 Zidovudine | IRIGHT